Page 20 - Core One News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Core One Labs Inc.: Core One Labs Highlights Key Points from International Investor Call Core One" the " Company") is pleased with the tremendous turnout on the International Investors' Call held earlier today. Core One's Chairman, Dr. Robert E.W. Hancock and Chief Executive Officer, Joel Shacker provided participants an update on the Company's current Intellectual Property and patent application process, cost to produce psilocybin, and the commercial viability. Highlights Intellectual Property and Patent Process Dr. Hancock announced that the Company has assembled the necessary data for its ...

Press release content from Accesswire. The AP news staff was not involved in its creation. Core One Labs Highlights Key Points from International Investor Call February 11, 2021 GMT VANCOUVER, BC / ACCESSWIRE / February 10, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (“Core One” the “Company”) is pleased with the tremendous turnout on the International Investors’ Call held earlier today. Core One’s Chairman, Dr. Robert E.W. Hancock and Chief Executive Officer, Joel Shacker provided participants an update on the Company’s current Intellectua...

Press release content from Accesswire. The AP news staff was not involved in its creation.

(6) VANCOUVER, BC / ACCESSWIRE / February 6, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62)(WKN:A2P8K3) (the "Company") announces that it has engaged Donohoe Advisory Associates LLC ("Donohoe Advisory") in connection with its efforts to seek a listing for its common shares on a NASDAQ Stock Market. The Company expects that listing its common shares on NASDAQ will provide increased investor awareness and market liquidity for shareholders. Donohoe Advisory was founded by Dave Donohoe in 2004, and since that time the firm has successfully represented hundreds of companies i...

Core One Labs Inc.: Core One Labs Announces Its Entrance into the Ketamine Space with Proposed Acquisition of Ketamine Infusion Centers of Texas Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the " Company") a biotechnology research and development company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy is pleased to announce it has entered into a letter of intent (the " Letter of Intent") dated January 20, 2021 with Ketamine Infusion Centers of Texas, LLC (" KICT"), an...